HealthWorld

4th February World Cancer Day: A Comprehensive Overview of the Global Cancer Burden and the Call for Equitable Care

As we approach World Cancer Day, the International Agency for Research on Cancer (IARC), a specialized cancer agency of the World Health Organization (WHO), has released new estimates revealing the extensive global burden of cancer. These estimates, derived from the best available data of 2022, underscore the increasing prevalence of cancer, its disproportionate impact on underserved populations, and the pressing need to address worldwide cancer inequities. This blog delves into the IARC's findings, the global survey results on universal health coverage (UHC) and cancer care, and the urgent call for equitable access to cancer and palliative care services.

The Growing Global Cancer Burden

In 2022, the world witnessed an estimated 20 million new cancer cases and 9.7 million cancer-related deaths, with 53.5 million people living within five years of a cancer diagnosis. The data highlights a stark reality: approximately one in five individuals will develop cancer in their lifetime, with the risk of death from the disease being significantly higher in men (1 in 9) than in women (1 in 12).

The WHO Survey on Universal Health Coverage and Cancer

A WHO survey encompassing 115 countries has revealed that a mere 39% of these countries incorporate the essentials of cancer management into their financed health benefit packages (HBP) for all citizens. Even fewer, 28%, extend their coverage to include palliative care services, underscoring a significant gap in global health care systems' ability to provide comprehensive cancer care.

Predominant Cancer Types in 2022

Lung, breast, and colorectal cancers emerge as the leading cancer types, together accounting for a substantial portion of new cases and deaths worldwide. Lung cancer alone led to 2.5 million new cases, making it the most common and the deadliest cancer globally. The persistence of tobacco use, especially in Asia, has been identified as a significant contributor to lung cancer's prevalence.

Disparities in Cancer Incidence and Mortality

The incidence and mortality rates of cancer vary significantly by gender and geographical location. For instance, breast cancer remains the most diagnosed cancer among women globally, while lung cancer is the leading cause of cancer death. The burden of cervical cancer, predominantly affecting women in sub-Saharan Africa, illustrates the potential for eliminating such diseases through global health initiatives like the WHO Cervical Cancer Elimination Initiative.

Addressing Cancer Inequity

The data from IARC and WHO highlight stark inequities in cancer burden correlated with the Human Development Index (HDI). In high-HDI countries, women are more likely to be diagnosed with breast cancer but less likely to die from it compared to those in low-HDI countries, where late diagnosis and lack of access to quality treatment significantly increase mortality rates.

The global survey also points to substantial disparities in the inclusion of cancer-related services in HBP, especially between high and low-income countries. For example, lung cancer-related services and radiation therapy are far more likely to be covered in HBPs of high-income countries, emphasizing the urgent need for global investments to bridge these gaps.

The Path Forward

As we look towards 2050, projections indicate a 77% increase in new cancer cases, with the most significant absolute and proportional increases expected in high and low HDI countries, respectively. This anticipated rise in cancer cases underscores the importance of concerted global efforts to address the disease's burden through early detection, treatment, and equitable access to care.

The latest findings from the IARC and WHO serve as a clarion call to the global community to address the growing burden of cancer and the significant disparities in cancer care. It's imperative to bolster political will, enhance investments, and implement effective policies to ensure that cancer care becomes a universal health coverage reality, irrespective of geographical or economic barriers. The path to achieving this goal involves a multi-faceted approach, including strengthening health systems, promoting cancer research, and ensuring equitable access to quality cancer care for all individuals.

Back to top button